Patients undergoing craniotomy for supratentorial mass
Conditions
Brief summary
hemodynamic change observed at the time of placement of the spiked headrest (Mayfield's headrest).
Detailed description
Hemodynamic variation during skin incision, flap and dura mater incision, Analysis of intraoperative parameters (heart rate, blood pressure, Response and State Entropy (RE/SE), Surgical Plethysmographic Index (SPI) at the time of block, incision, craniectomy and dura mater incision., Absence of complications related to the block (AL toxicity, infection, etc.), Level of sleepiness in USPA (RASS score), Pain scores at the different time intervals shown in the table from the PCU to hospital discharge, Morphine use in the PACU and in the hospital ward, Length of hospital stay, Evaluation of QoR15 on D-1, D+1, D+3, D+7, Evaluation of patient satisfaction via the EVAN-G score, Presence of PONV, constipation, pruritus during hospitalization
Interventions
DRUGChlorure de sodium 0
DRUGPropofol B. Braun 2 % (20 mg/ml)
DRUGsolution injectable/ pour perfusion
DRUGLinisol 1 %
DRUGsolution injectable
DRUGUltiva 5 mg poudre pour solution à diluer pour solution injectable/pour perfusion
DRUGParacetamol Fresenius Kabi 10 mg/ml solution pour perfusion
DRUGEtoricoxib AB 60 mg filmomhulde tabletten
DRUGNimbex 2 mg/ml
Sponsors
Centre hospitalier universitaire de Liege
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| hemodynamic change observed at the time of placement of the spiked headrest (Mayfield's headrest). | — |
Secondary
| Measure | Time frame |
|---|---|
| Hemodynamic variation during skin incision, flap and dura mater incision, Analysis of intraoperative parameters (heart rate, blood pressure, Response and State Entropy (RE/SE), Surgical Plethysmographic Index (SPI) at the time of block, incision, craniectomy and dura mater incision., Absence of complications related to the block (AL toxicity, infection, etc.), Level of sleepiness in USPA (RASS score), Pain scores at the different time intervals shown in the table from the PCU to hospital discharge, Morphine use in the PACU and in the hospital ward, Length of hospital stay, Evaluation of QoR15 on D-1, D+1, D+3, D+7, Evaluation of patient satisfaction via the EVAN-G score, Presence of PONV, constipation, pruritus during hospitalization | — |
Countries
Belgium
Outcome results
None listed